⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockIsraelNYSE

TEVA

Teva Pharmaceutical Industries Limited

Healthcare · Drug Manufacturers - Specialty & Generic

36.85USD

+0.0900 (+0.24%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 36.85
P/E60.7
Dvd Ind Yld—
P/B5.53
P/S3.0
Curr EV/T12M EBITDA21.6
Mkt Cap (USD)42.8B
Curr EV (USD)56.1B
2)

Per Share Data

EPS T12M0.60
DPS0.01
Bk Val Per Sh6.65
Rev/Sh12.11
Cash/Sh3.14
Curr Shares Out1,165.3M
FCF/Sh1.16
3)

Cash Flow Analysis

P/CF22.6
Curr P/FCF31.8
CF/NI2.7
Dvd P/O1.7%
Cash Gen/Cash Reqd3.4
Csh Dvd Cov158.2
CFO/Sales13.5%
Eff Interest Rate36.9%
4)

Growth Potential

Dil EPS 1Y Gr183.4%
Cap 1Y Gr36.0%
BPS 1Y Gr43.2%
R&D To Sales0.7%
Retention Rate98.3%
Rev 1Y Gr4.3%
FCF 1Y Gr53.3%
Assets 1Y Gr3.6%
5)

Profitability

EBITDA2.6B
EBIT1.6B
Operating Margin11.4%
Pretax Margin5.0%
Net Margin5.0%
ROA1.8%
ROE9.7%
ROC3.8%
Asset Turnover0.35
6)

Structure

Current Ratio0.88
Quick Ratio0.46
Debt/Assets83.6%
Debt/Com Eq429.9%
Net Debt/EBITDA11.45
Tot Debt/Capital81.1%
Gross Margin64.4%
EBIT/Int Exp1.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.